GASTROINTESTINAL NEOPLASMS
Clinical trials for GASTROINTESTINAL NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new GASTROINTESTINAL NEOPLASMS trials appear
Sign up with your email to follow new studies for GASTROINTESTINAL NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Major trial tests new weapon against spreading colon cancer
Disease control Recruiting nowThis study is testing whether a new drug, PF-08634404, works better than the current standard treatment for people whose colorectal cancer has spread. About 800 adults who haven't yet received treatment for their advanced cancer will be randomly assigned to get either the new dru…
Matched conditions: GASTROINTESTINAL NEOPLASMS
Phase: PHASE3 • Sponsor: Pfizer • Aim: Disease control
Last updated Apr 01, 2026 19:56 UTC
-
First patients to try new pill for Tough-to-Treat stomach tumors
Disease control Recruiting nowThis is the first-ever study in people for an experimental pill called IDRX-42. It aims to find a safe dose and see if it can help control advanced gastrointestinal stromal tumors (GIST) that have spread or cannot be removed by surgery. The study will enroll adults whose cancer h…
Matched conditions: GASTROINTESTINAL NEOPLASMS
Phase: PHASE1 • Sponsor: IDRx Inc. - A GSK Company • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New hope for Tough-to-Treat gut cancers in global trial
Disease control Recruiting nowThis study is testing a new drug called GSK5764227 for people with advanced stomach, colon, rectal, or pancreatic cancers that have spread and cannot be removed by surgery. The trial aims to see if the drug is safe, how well it works to shrink tumors, and how the body processes i…
Matched conditions: GASTROINTESTINAL NEOPLASMS
Phase: PHASE1, PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
First-in-Human trial launches for new weapon against tough GI cancers
Disease control Recruiting nowThis is the first study in people of an experimental drug called JNJ-89402638 for advanced colorectal and stomach cancers that have spread and stopped responding to standard treatments. The main goals are to find a safe dose and see how the body handles the drug, both alone and w…
Matched conditions: GASTROINTESTINAL NEOPLASMS
Phase: PHASE1 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
New hope for Tough-to-Treat stomach cancer: major trial tests experimental drug
Disease control Recruiting nowThis study is testing whether a new drug called IDRX-42 works better than the current standard drug, sunitinib, for people with advanced gastrointestinal stromal tumors (GIST) that have spread or cannot be removed by surgery. The trial will involve 450 adults whose cancer has pro…
Matched conditions: GASTROINTESTINAL NEOPLASMS
Phase: PHASE3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC
-
New camera tech aims to spot surgical trouble before it starts
Diagnosis Recruiting nowThis study is testing a new camera-based method (iPPG) against the current standard dye method (ICG) to see which is better at checking blood flow in tissue during surgery for stomach or colorectal cancer. The goal is to help surgeons make better decisions during the operation to…
Matched conditions: GASTROINTESTINAL NEOPLASMS
Phase: NA • Sponsor: Saint Petersburg State University, Russia • Aim: Diagnosis
Last updated Mar 17, 2026 13:09 UTC
-
Virtual reality goggles could offer Drug-Free relief for cancer pain
Symptom relief Recruiting nowThis study is testing whether virtual reality (VR) can help reduce pain and improve quality of life for people with gastrointestinal cancers. Researchers will compare three approaches: VR that teaches pain management skills, VR designed to distract from pain, and a basic VR contr…
Matched conditions: GASTROINTESTINAL NEOPLASMS
Phase: NA • Sponsor: Cedars-Sinai Medical Center • Aim: Symptom relief
Last updated Mar 30, 2026 14:34 UTC
-
Poop pills tested to fight cancer drug sickness
Symptom relief Recruiting nowThis study is testing if a fecal microbiota transplant (FMT), which transfers healthy gut bacteria from a donor, can help reduce nausea, vomiting, and diarrhea caused by chemotherapy or targeted therapy. It will involve 90 adults with advanced gastrointestinal cancers who have al…
Matched conditions: GASTROINTESTINAL NEOPLASMS
Phase: PHASE1 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Symptom relief
Last updated Mar 23, 2026 15:15 UTC
-
Does pill or IV chemo disrupt sleep more? new study investigates
Symptom relief Recruiting nowThis study aims to understand if taking chemotherapy as a pill versus through an IV affects sleep quality and depression levels in patients with non-metastatic gastrointestinal cancers. Researchers will follow 82 patients, measuring their sleep and mood at the start of treatment …
Matched conditions: GASTROINTESTINAL NEOPLASMS
Sponsor: Ankara Etlik City Hospital • Aim: Symptom relief
Last updated Mar 12, 2026 13:51 UTC
-
Artificial intelligence joins the fight against gut cancer
Knowledge-focused Recruiting nowThis study is testing whether artificial intelligence (AI) software can help doctors better detect and identify early-stage growths in the stomach and colon during routine camera examinations. It involves about 1,650 adults who are already scheduled for a standard endoscopy. The …
Matched conditions: GASTROINTESTINAL NEOPLASMS
Sponsor: Portsmouth Hospitals NHS Trust • Aim: Knowledge-focused
Last updated Mar 13, 2026 15:06 UTC